Stated plainly: 6.67 mg/mL · cagrilintide.
Both of these get recommended confidently by different people, which suggests neither is obviously right.
My constraints are cost, measurement resolution and how much handling I am prepared to do — in roughly that order.
Is there a defensible reason to prefer one, or is this a coin flip?
At 6.67 mg/mL a 0.25 mg draw is 3.7 units on a U-100 barrel and a 2.4 mg draw is 36. Those two numbers decide it, because the concentration is only sensible relative to the smallest and largest volumes you will actually measure with it. 3.7 units is too little of the scale to read honestly — half a graduation is 13 per cent of that dose — so going lower in concentration buys resolution you cannot get back after reconstitution. The other consideration is time: a vial you will finish in a fortnight can be concentrated, and a vial you will draw from for months should be split at reconstitution instead.
Start from the dose you intend to draw and work backwards to the volume that puts it in a readable part of the barrel.
The other direction: 10 mg in 3 mL is 3.33 mg/mL, and a 0.5 mg dose becomes 0.15 mL, or 15 units. More barrel, easier reading, and a larger fraction of the vial volume lost to dead space across the same number of draws.
| Vial | Diluent | Concentration | 0.25 mg | 0.5 mg | 1 mg | 2.5 mg |
|---|---|---|---|---|---|---|
| 5 mg | 1 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 5 mg | 2 mL | 2.5 mg/mL | 10 u | 20 u | 40 u | 100 u |
| 10 mg | 1 mL | 10 mg/mL | 2.5 u | 5 u | 10 u | 25 u |
| 10 mg | 2 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 10 mg | 3 mL | 3.33 mg/mL | 7.5 u | 15 u | 30 u | 75 u |
Units are U-100 insulin units, where 1 unit = 0.01 mL. Divide dose by concentration for millilitres, then multiply by 100.
Round to a diluent volume you can measure accurately. Measuring 1.00 mL on a 1 mL syringe is reliable; measuring 1.37 mL on anything is not, and the error propagates into every dose.
Published content assay results across the independent testing services show nominal and measured content differing by one to ten per cent, which makes content the dominant term in dose error.
Measure a volume you can actually measure. Round numbers, real syringes.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsAnswering this needs the syringe you actually own, because the barrel graduations decide what "readable" means.
Vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.
The part that matters: content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.
Nothing here is medical advice, and research-use material is not approved for human use.
Concentration equals content over volume, and content is not label claim.
Aim for a dose volume somewhere between about 10 and 30 units on a U-100 barrel and the reading problem disappears.
Dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.
Worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.
Nominal vial volumes in the standard 2R and 3R glass sizes have published brimful capacities well above the nominal fill, but the usable volume is bounded by the stopper displacement.
Write the concentration on the label at reconstitution, in units per dose.
edited 15 Feb 2025 by tabular_nums — added the placebo-arm figures
This is the one decision in the whole preparation sequence that cannot be revised later, which is why it is worth thirty seconds of arithmetic.
Write the concentration and the resulting units-per-dose on the vial label at reconstitution. The arithmetic that is obvious now will not be obvious at six in the morning three weeks from now.
Insulin syringe barrel graduations are typically 1 unit on a 0.3 mL barrel, 1 unit on a 0.5 mL barrel and 2 units on a 1 mL barrel, which is why the barrel size changes what is readable.
Do not change the diluent volume between vials of a titration without recalculating; it is the commonest source of a ten-fold error.
Choose the volume that puts your largest intended dose between 10 and 30 units. Everything else follows.
edited 3 Mar 2025 by Dr_Ingrid_Baumgartner — updated for the 2026 guidance change
The honest answer is that a wide range of volumes works and that the extremes at either end cause avoidable problems.
For a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.
U-100 means 100 units per millilitre by definition, so 1 unit is 0.01 mL and volume in millilitres times one hundred gives units. Every conversion here reduces to that.
Check the vial can physically hold the volume before you draw it up.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.